NDC 66215-718-01

UPTRAVI 1800 ug/10mL

Selexipag · INJECTION, POWDER, FOR SOLUTION

No Recall History

UPTRAVI is a injection, powder, for solution containing selexipag at a strength of 1800 ug/10mL. Manufactured by Actelion Pharmaceuticals US, Inc..

Key Facts

Brand Name: UPTRAVI
Generic Name: Selexipag
NDC Code (Package): 66215-718-01
NDC Code (Product): 66215-718
Manufacturer: Actelion Pharmaceuticals US, Inc.
Strength: 1800 ug/10mL
Dosage Form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Marketing Status
Application #: NDA214275
Marketing Start: 07/29/2021

Recall History

No Recall History

View Full Drug Page

UPTRAVI — All Packages

Not medical advice. This information is for reference only. Always consult your doctor or pharmacist.